Insider Selling: Mettler-Toledo International Inc. (NYSE:MTD) Insider Sells 140 Shares of Stock

Mettler-Toledo International Inc. (NYSE:MTDGet Free Report) insider Gerry Keller sold 140 shares of Mettler-Toledo International stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the transaction, the insider now owns 6 shares of the company’s stock, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Mettler-Toledo International Stock Up 0.4 %

Shares of NYSE MTD traded up $4.89 during mid-day trading on Wednesday, hitting $1,262.75. 73,780 shares of the company were exchanged, compared to its average volume of 136,148. Mettler-Toledo International Inc. has a 1-year low of $1,068.33 and a 1-year high of $1,546.93. The stock has a 50 day simple moving average of $1,338.57 and a 200-day simple moving average of $1,388.61. The firm has a market cap of $26.64 billion, a price-to-earnings ratio of 34.16, a price-to-earnings-growth ratio of 4.15 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTDGet Free Report) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.00 by $0.21. The business had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. Analysts anticipate that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on MTD shares. Stifel Nicolaus decreased their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Evercore ISI lifted their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Wells Fargo & Company decreased their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday, November 11th. Finally, Robert W. Baird reduced their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $1,338.75.

View Our Latest Stock Analysis on MTD

Institutional Trading of Mettler-Toledo International

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. State Street Corp increased its position in Mettler-Toledo International by 1.0% during the 3rd quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock worth $1,431,693,000 after purchasing an additional 9,009 shares in the last quarter. Geode Capital Management LLC grew its holdings in Mettler-Toledo International by 0.8% in the 3rd quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after buying an additional 4,166 shares during the period. PineStone Asset Management Inc. grew its holdings in Mettler-Toledo International by 127.4% in the 2nd quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock valued at $362,855,000 after buying an additional 145,453 shares during the period. Barclays PLC grew its holdings in Mettler-Toledo International by 8.3% in the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after buying an additional 19,609 shares during the period. Finally, Loomis Sayles & Co. L P grew its holdings in Mettler-Toledo International by 1.8% in the 3rd quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock valued at $314,790,000 after buying an additional 3,644 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

(Get Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Further Reading

Insider Buying and Selling by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.